The Core: Reporting, Insights & Views

India’s diagnostics giants are racing past routine blood tests into genomics, AI pathology and liquid biopsy, building high-tech moats that discounters cannot copy and the market is already pricing in.

Top Stories

The Hi-Tech Behind India’s Diagnostic Giants’ Premium Valuations

Top Stories

Air India And IndiGo Chase Demand With Simpler, Cheaper Fares

Why India's FMCG Majors Are Buying Their Way Into Nutraceuticals

India’s IT Bellwether TCS Paints An AI Future Its Books Don't Show

Honda Bets On Imports And SUVs To Rebuild Its India Presence

Podcast

Meet Your New Recruiter: AI

What Signals Are The Markets Really Looking For?

Markets Recalculate Impact As Trump Signals End Of Truce

How India's exports to the US jumped in the tumultuous year of Trump Tariffs

Foreign Portfolio Investors Are Returning To Indian Markets

All Eyes On Q1 Results

Markets Set For Firmer Week Ahead

News

Meet Your New Recruiter: AI

Air India And IndiGo Chase Demand With Simpler, Cheaper Fares

The Hi-Tech Behind India’s Diagnostic Giants’ Premium Valuations

What Signals Are The Markets Really Looking For?

Markets Recalculate Impact As Trump Signals End Of Truce

categories

useful links

Follow us

Core.

Core.